opioid buprenorphine is a drug used to treat opiate addiction. It is usually given by a physician on the treatment at home. Heroin and other opiate addictions can be treated safely and has the procedure for obtaining the FDA took a major obstacle.

While buprenorphine is the generic name of a chemical form of buprenorphine is just a semi-synthetic opioid. Suboxone and Subutex are registered trademarks of buprenorphine-based drugs registered.

Suboxone contains 4 parts and 1 part buprenorphine naloxone. Only active ingredient in Subutex is buprenorphine. Most physicians prefer Suboxone because it is less likely to be diverted because of the presence of naloxone. While Suboxone for the U.S. market was invented, it is in other countries.

buprenorphine

Cure for the treatment of opiate analgesics such as buprenorphine than other fourth methadone, naltrexone may act and LAAM (l-alpha-acetyl-methadol). Buprenorphine unique effects and pharmacology make it an attractive and clinically useful treatment. For example, buprenorphine produces less euphoria than morphine and heroin. much less sedation and respiratory depression by buprenorphine and other opiates is caused, heroin overdose dangerous if breathing slows. Even with high doses of buprenorphine – to 100-times the dose at which it produces analgesia – does not produce harmful effects of the respiratory tract. “The respiratory depression caused by buprenorphine, not of clinical concern,” says Segal, “making it a highly attractive alternative treatment.”

Buprenorphine is an agonist, which products are chemicals that stimulate the binding to receptors, and opiates. limited side effects


The use of Suboxone as a treatment in practice for opioid dependence in 6 phases:

pre-screening: The purpose of this phase is to examine whether the treatment in practice the best approach for a particular patient, it is composed of a short interview with lead. phone or in person

admission. Patients admitted for treatment in the pre-screening process are then scheduled for admission To the patient record suitability for treatment in practice. The main purpose of the contribution

induction. The main goal is certainly the opioid withdrawal removed as quickly as possible should be warned about possible with appropriate doses of Suboxone, the patient. The symptoms of mild opiate withdrawal This phase usually lasts two to five days and must be immediately after the addition of stabilizing

: … “Refined” At this stage the patient Suboxone dose is The aim is the minimum dose needed to find the patient in the treatment and monitoring of the effects of opiate withdrawal, maintain and use, this is a gradual adjustment of the dosage

maintenance performed..

General objectives are:

prevent or suppress symptoms of opioid withdrawal opioid cravings

self-administered opioids are attenuated for

medically supervised withdrawal use: only if the patient and doctor agree that it is advantageous, it is done for them Suboxone The patient dose should be tapered slowly at a rate. Both doctors and patients consider acceptable.

Patients should focus on the possibility of slight, temporary withdrawal symptoms that can reduce the energy produced, decreased appetite, irritability, insomnia.

If Suboxone treatment, therapy and application of psycho-social support should be continued and regular monitoring. Recovery of the individual and well-being depend on these steps.


Suboxone Treatment